231 results
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
in securities litigation or shareholder derivative litigation in connection with the Merger, and this could divert the attention of SciSparc and AutoMax … litigation or shareholder derivative litigation frequently follows the announcement of certain significant business transactions, such as the sale
20-F/A
2023 FY
SPRC
SciSparc Ltd
2 May 24
Annual report (foreign) (amended)
9:18am
, in connection with the aforementioned litigation, the shares of Evero Health Ltd. held by Capital Point are dormant and were forfeited by Evero
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
the meaning of the Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements regarding the structure … Financial Statements
Shareholder Litigation
Certain Adjustments
CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY
No Restraints
Shareholder Approval
6-K
EX-99.3
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, SciSparc is using forward-looking statements
6-K
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
statements” within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements
6-K
EX-99.2
aj2qi
11 Apr 24
Agreement and Plan of Merger
4:05pm
6-K
EX-99.1
wmgal52
11 Apr 24
Agreement and Plan of Merger
4:05pm
S-8
9nijl4j4xhcttv r4i
1 Apr 24
Registration of securities for employees
5:11pm
6-K
EX-99.1
6c560bst
27 Mar 24
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
9:18am
6-K
EX-99.1
2xct8c
15 Mar 24
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
8:00am
6-K
awhgz2 69
13 Mar 24
Report of Foreign Private Issuer
9:06am
6-K
EX-99.3
cjzy p3a6trz5u3mn
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
6-K
EX-99.1
5y1nzoiuqcn
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
6-K
EX-99.1
2clh2y8ipsgjvqqh
29 Feb 24
Report of Foreign Private Issuer
9:07am
F-1
p9307m m3
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-99.1
sv6ui9pzen6qt32d2u7
27 Feb 24
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
8:35am
6-K
EX-99.1
zm2gxv9
20 Feb 24
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
4:27pm
6-K
EX-99.1
e5cpiy1
29 Jan 24
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
4:00pm
6-K
EX-4.1
k05ae8
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am